The Vanguard Study: Testing a New Way to Screen for Cancer

Recruiting now · Not applicable

Conditions studied: Bladder Carcinoma, Breast Carcinoma, Colorectal Carcinoma, Esophageal Carcinoma, Gastric Carcinoma, Liver Carcinoma, Lung Carcinoma, Malignant Solid Neoplasm, Ovarian Carcinoma, Pancreatic Carcinoma, Prostate Carcinoma

In brief

The Vanguard Study is a feasibility study to explore several aspects of evaluating multi-cancer detection (MCD) tests in a future definitive randomized controlled trial. An MCD test measures markers in the blood in order to screen for multiple cancers simultaneously. There is a need to understand how MCDs may work as cancer screening tools. The goal of cancer screening is to reduce the burden of cancer by identifying cancers before they show symptoms or signs, when treatment is likely to be most effective. In this study, adults aged 45-75 without cancer will be randomly assigned to one of 3 groups: 2 separate MCD test groups or a control group. These two MCD tests will not be compared to each other but will be compared to cancers detected in the control group. This study will provide early information on how well MCD tests perform as cancer screening tools. It will also help researchers understand how patients and their doctors make decisions about their care when the MCD test result comes back as normal (negative) or abnormal (positive).

Key facts

Study ID

NCT06995898

Run by

National Cancer Institute (NCI)

People needed

24000

Starts

2025-06-18

Expected to finish

2029-06-30

Last updated by the study team

2026-07-08

Who can join

Age: 45 and older, up to 75. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Ages 45-75 years old
• Agree to provide blood samples for possible MCD testing at enrollment and at 1 year following enrollment
• Agree to allow collection of information from their medical records for study-related purposes
• Understand and be able to complete informed consent and participant questionnaires in English, Spanish, or Arabic
• Note: Eligibility for Spanish and Arabic languages are at the Hub's discretion

You may not qualify if…

• Solid malignant tumor or blood cancer diagnosis, with or without treatment, within the last 5 years
• Note: Persons with a history of in situ cancers (e.g., ductal carcinoma in situ of the breast, cervical cancer in situ, atypical melanocytic hyperplasia or melanoma in situ) or nonmelanoma skin cancer are eligible
• Ongoing cancer diagnostic work-up
• Ongoing participation in another study of an investigational cancer screening test or technology
• Currently breastfeeding or pregnant, or planning to become pregnant in the next year

Where it is running

• Kaiser Permanente-Division of Research — Pleasanton, California, United States (enrolling)
• Keefe Memorial Hospital — Cheyenne Wells, Colorado, United States (enrolling)
• Kaiser Permanente-Franklin — Denver, Colorado, United States (enrolling)
• Poudre Valley Hospital — Fort Collins, Colorado, United States (enrolling)
• Cancer Care and Hematology-Fort Collins — Fort Collins, Colorado, United States (enrolling)
• UCHealth Greeley Hospital — Greeley, Colorado, United States (enrolling)
• Kaiser Permanente-Rock Creek — Lafayette, Colorado, United States (enrolling)
• Kaiser Permanente-Lone Tree — Lone Tree, Colorado, United States (enrolling)
• Medical Center of the Rockies — Loveland, Colorado, United States (enrolling)
• Kaiser Permanente Moanalua Medical Center — Honolulu, Hawaii, United States (enrolling)
• Walter Reed National Military Medical Center — Bethesda, Maryland, United States (enrolling)
• Henry Ford Cancer Institute-Downriver — Brownstown, Michigan, United States (enrolling)
• Henry Ford Health Center - Brownstown — Brownstown, Michigan, United States (enrolling)
• Henry Ford Health Center - Chesterfield — Chesterfield, Michigan, United States (enrolling)
• Henry Ford Macomb Hospital-Clinton Township — Clinton Township, Michigan, United States (enrolling)
• Henry Ford Medical Center-Fairlane — Dearborn, Michigan, United States (enrolling)
• Henry Ford Hospital — Detroit, Michigan, United States (enrolling)
• Henry Ford Medical Center - Detroit Northwest — Detroit, Michigan, United States (enrolling)
• Henry Ford Medical Center-Cottage — Grosse Pointe Farms, Michigan, United States (enrolling)
• Henry Ford Medical Center - Livonia — Livonia, Michigan, United States (enrolling)
• Henry Ford Medical Center-Columbus — Novi, Michigan, United States (enrolling)
• Henry Ford Medical Center - Plymouth — Plymouth, Michigan, United States (enrolling)
• Henry Ford Medical Center - Royal Oak — Royal Oak, Michigan, United States (enrolling)
• Henry Ford Medical Center — Sterling Heights, Michigan, United States (enrolling)
• Henry Ford Medical Center - Troy — Troy, Michigan, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.